CRIS Current Research Information System

MANFREDI, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.999
AS - Asia 17.744
EU - Europa 17.681
SA - Sud America 1.334
AF - Africa 929
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 5
Totale 55.708
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.858
GB - Regno Unito 5.486
CN - Cina 5.256
SG - Singapore 4.763
VN - Vietnam 3.972
IT - Italia 2.386
UA - Ucraina 2.299
DE - Germania 2.289
FR - Francia 1.322
SE - Svezia 1.300
HK - Hong Kong 1.132
RU - Federazione Russa 1.023
IN - India 1.018
BR - Brasile 954
IE - Irlanda 518
JP - Giappone 497
ZA - Sudafrica 360
EE - Estonia 337
KR - Corea 324
NL - Olanda 222
SC - Seychelles 209
AR - Argentina 163
FI - Finlandia 151
CI - Costa d'Avorio 134
ID - Indonesia 100
PH - Filippine 98
TG - Togo 98
TH - Thailandia 97
BD - Bangladesh 75
IQ - Iraq 63
CA - Canada 60
EC - Ecuador 58
TR - Turchia 53
GR - Grecia 52
MX - Messico 51
CH - Svizzera 48
BG - Bulgaria 41
CO - Colombia 41
LB - Libano 37
MY - Malesia 36
PL - Polonia 34
PY - Paraguay 33
AT - Austria 32
JO - Giordania 32
CL - Cile 29
TW - Taiwan 29
SA - Arabia Saudita 28
UZ - Uzbekistan 28
PK - Pakistan 27
BE - Belgio 24
VE - Venezuela 24
MA - Marocco 22
ES - Italia 21
KE - Kenya 19
PE - Perù 19
ET - Etiopia 16
IR - Iran 15
RO - Romania 15
AU - Australia 14
CZ - Repubblica Ceca 14
EG - Egitto 14
TN - Tunisia 12
LT - Lituania 11
HU - Ungheria 9
NG - Nigeria 9
NP - Nepal 9
SK - Slovacchia (Repubblica Slovacca) 9
DO - Repubblica Dominicana 8
PS - Palestinian Territory 8
DZ - Algeria 7
KZ - Kazakistan 7
SI - Slovenia 7
BO - Bolivia 6
IL - Israele 6
UY - Uruguay 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
JM - Giamaica 5
OM - Oman 5
PT - Portogallo 5
DK - Danimarca 4
EU - Europa 4
KG - Kirghizistan 4
AO - Angola 3
AZ - Azerbaigian 3
BY - Bielorussia 3
CR - Costa Rica 3
HR - Croazia 3
NI - Nicaragua 3
PA - Panama 3
SN - Senegal 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
CG - Congo 2
GH - Ghana 2
GT - Guatemala 2
KW - Kuwait 2
LK - Sri Lanka 2
LU - Lussemburgo 2
MU - Mauritius 2
Totale 55.663
Salva come PNG Salva come JPEG
Città #
Southend 4.922
Singapore 3.089
Jacksonville 1.672
Fairfield 1.530
Ashburn 1.431
Hong Kong 1.091
Hefei 1.045
Chandler 1.008
Wilmington 942
Princeton 936
Dong Ket 901
Santa Clara 782
Woodbridge 752
Ho Chi Minh City 682
San Jose 650
Seattle 646
Houston 642
Hanoi 585
Boardman 544
Lauterbourg 541
Cambridge 539
Dublin 512
Nanjing 478
Tokyo 463
Ann Arbor 455
Westminster 454
Padova 449
Beijing 396
Bologna 370
Berlin 338
Los Angeles 291
Seoul 291
Mülheim 255
Milan 251
Dallas 225
Saint Petersburg 222
Jinan 214
Buffalo 212
Shenyang 199
Mahé 196
Medford 190
Hebei 148
Nanchang 140
Changsha 138
Helsinki 136
Abidjan 134
The Dalles 133
San Diego 124
Tianjin 117
Verona 113
Haiphong 106
Redondo Beach 100
Lomé 98
Des Moines 90
Rome 90
Jiaxing 84
Da Nang 83
Zhengzhou 82
Guangzhou 81
Hangzhou 81
São Paulo 81
Shanghai 75
New York 70
Dearborn 69
Kunming 66
Yubileyny 66
Bengaluru 64
Bangkok 59
Redmond 59
Norwalk 58
Olalla 57
Ningbo 54
Frankfurt am Main 53
Falls Church 52
Chicago 48
Lanzhou 46
Haikou 45
Phoenix 42
Rio de Janeiro 42
Ingolstadt 39
Jakarta 39
Biên Hòa 38
Wuhan 38
Hải Dương 36
Sofia 36
Bühl 35
Redwood City 35
Taizhou 35
Turin 34
Amman 32
London 32
Can Tho 31
Fuzhou 28
Orem 28
Taiyuan 27
Council Bluffs 26
Florence 26
Shenzhen 26
Xi'an 26
Nuremberg 24
Totale 35.246
Salva come PNG Salva come JPEG
Nome #
Update on the appropriate use of linezolid in clinical practice 573
Candidosi esofagea ricorrente in corso di infezione da HIV non associata ad evidente stato di immunodeficienza, ed in presenza di un trattamento antiretrovirale efficace 274
The destiny of italian prisoners in austro-hungarian pow camps during the first world war: Remembering the defeat of caporetto 100 years on 249
Assessing the impact of hepatitis C virus coinfection on lopinavir/ritonavir trough concentrations in HIV-infected patients. 238
Acute onset myopericarditis as unusual presentation of primary HIV infection 236
The plague which hit the city of Bologna in the year 1630 230
Turicella otitidis central venous-related bacteremia during pediatric acute lymphoblastic leukemia 223
Ultrastructural liver mitochondrial abnormalities in HIV/HCV-coinfected patients receiving antiretroviral therapy 216
A 2-year survey of bacteriologic profile and antimicrobial susceptibility levels of Enterococci in a large Italian teaching hospital. 211
Admission of foreign citizens to the general teaching hospital of Bologna, northeastern Italy: an epidemiological and clinical survey 211
A decade surveillance study of Mycobacterium xenopi disease and antimicrobial susceptibility levels in a reference teaching hospital of northern Italy: HIV-associated versus non-HIV-associated infection. 207
HIV enteropathy: undescribed ultrastructural changes of duodenal mucosa and their regression after triple antiviral therapy. A case report 203
Cardiovascular risk factors and ultrasound evaluation of carotid atherosclerosis in patients with HIV-1 infection. 198
Dual raltegravir-darunavir/ritonavir combination in virologically suppressed HIV-1-infected patients on antiretroviral therapy including a ritonavir-boosted protease inhibitor plus two nucleoside/nucleotide reverse transcriptase inhibitors 191
Reactivation of severe, acute pulmonary tuberculosis during treatment with pegylated interferon-alpha and ribavirin for chronic HCV hepatitis 190
Fatal long-term immunosuppressive therapy with uncontrolled repeat prescription 188
Myocardial infarction risk in HIV-infected patients: epidemiology, pathogenesis, and clinical management 187
Paradoxical response to intravenous immunoglobulin in a case of Parvovirus B19-associated chronic fatigue syndrome 187
Causes of hospitalization among Extra-European Union children in a large Hospital of Northern Italy, in a five-year observation period 186
Substitution of nevirapine or efavirenz for protease inhibitor versus lipid-lowering therapy for the management of dyslipidaemia. 185
Abacavir-induced febrile agranulocytosis and anaemia. 185
Plasma Levels of VCAM-1, ICAM-1, E-Selectin, and P-Selectin in 99 HIV-positive patients versus 51 HIV-negative healthy controls. 182
A novel antiretroviral class (fusion inhibitors) in the management of HIV infection. Present features and future perspectives of enfuvirtide (T-20) 181
Diffusa disseminazione cutanea di una leishmaniosi viscerale in corso di infezione da HIV: un percorso diagnostico e terapeutico. 181
Skeletal muscle toxicity in HIV-1-infected patients treated with a raltegravir-containing antiretroviral therapy: a cohort study. 181
A prospective evaluation of maraviroc administration in patients with advanced HIV disease and multiple comorbidities: focus on efficacy and tolerability issues 180
Prevalence of renal disease within an urban HIV-infected cohort in northern Italy. 180
Atypical progressive multifocal leukoencephalopathy in HIV with a high CD4 count: the use of magnetic resonance imaging plus spectrometry studies 178
Basic clinical-applied pharmacoeconomic features of antiretroviral therapy. A pilot single-centre study performed on around 1000 HIV-infected individuals receiving combined antiretroviral treatment 175
Management of Strongyloides stercoralis extensive infestation in a patient with Sjogren syndrome 174
Increasing pathomorphism of pulmonary tuberculosis: an observational study of slow clinical, microbiological, and imaging response of lung tuberculosis to specific treatment. Which role for linezolid? 172
Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management 171
Insulin resistance and diabetes mellitus in HIV-infected patients receiving antiretroviral therapy 170
Risk factors and occurrence of rash in HIV-positive patients not receiving nonnucleoside reverse transcriptase inhibitors: data from a randomized study evaluating use of protease inhibitors in nucleoside-experienced patients with very low CD4 levels (<50 cells/mmc) 170
Protease inhibitor monotherapy as maintenance regimen in patients with HIV infection. 170
A puzzling microbiological and clinical discrepancy in the management of acute, severe skin-soft tissue and joint staphylococcal infection. In vitro antimicrobial susceptibility to glycopeptides, versus in vivo clinical efficacy of linezolid alone 169
Abdominal neoplasia with sarcomatoid features as the presenting illness of a patient with a newly diagnosed HIV infection and no AIDS-related disorders. Case report, clinical and diagnostic features, and literature discussion 169
Chronic hepatitis with diffuse steatosis and slight fibrosis related to etretinate therapy 168
Two-Year Treatment with Rosuvastatin Reduces Carotid Intima-Media Thickness in HIV Type 1-Infected Patients Receiving Highly Active Antiretroviral Therapy with Asymptomatic Atherosclerosis and Moderate Cardiovascular Risk. 167
Pancreotoxicity of propofol sedation during purulent meningitis. 166
La peste di Giustiniano (prima parte) 166
No correlation between statin exposure and incident diabetes mellitus in HIV-1-infected patients receiving combination antiretroviral therapy 166
Cytokine storm in aged people with CoV-2: possible role of vitamins as therapy or preventive strategy 166
Gynecomastia, lipodystrophy syndrome, and dyslipidemia occurring or worsening during antiretroviral regimens other than protease inhibitor-based ones. 165
Measles outbreak in the city of Bologna, December 2007 to May 2008 165
Disseminated cutaneous leishmaniasis after visceral disease in a patient with AIDS 165
A prospective comparison of hepatotoxicity of the two currently available non-nucleoside reverse transcriptase inhibitors in a homogeneous case-mix of HIV-infected patients treated for the first time with efavirenz or nevirapine, according to their different baseline conditions 164
Bone mass loss in patients with human immunodeficiency virus type 1 infection: association with male sex and protease inhibitor therapy 163
A very particular case of long-term non-progressor: nineteen consecutive years of follow-up in the absence of any detectable HIV-1 viraemia 163
Plasma concentrations of efavirenz, darunavir/ritonavir and raltegravir in HIV-HCV-coinfected patients without liver cirrhosis in comparison with HIV-monoinfected patients. 163
Incidence of renal toxicity in HIV-infected, antiretroviral-naïve patients starting tenofovir/emtricitabine associated with efavirenz, atazanavir/ritonavir, or lopinavir/ritonavir 162
Abacavir-lamivudina versus tenofovir-emtricitabina più atazanavir-ritonavir nella semplificazione dell'HAART per dislipidemia 162
Risk of premature atherosclerosis and ischemic heart disease associated with HIV infection and antiretroviral therapy 161
Prospective, open-label comparative study of liver toxicity in an unselected population of HIV-infected patients treated for the first time with efavirenz or nevirapine 160
Candida albicans panuveitis and an uneven therapeutic ground, passing through all available and potentially effective antifungal drugs: fluconazole, liposomal amphotericin B, caspofungin, and voriconazole 160
Liposomal amphotericin B and HIV-associated visceral leishmaniasis: concerns about nephrotoxicity and administration schedule 160
Voriconazole proves effective in long-term treatment of a cerebral cryptococcoma in a chronic nephropathic HIV-negative patient, after fluconazole failure 160
Rosuvastatin for the treatment of hyperlipidaemia in HIV-infected patients receiving protease inhibitors: a pilot study. 159
Dyslipidaemia associated with antiretroviral therapy in HIV-infected patients. 159
Long-term "self-managed" immunosuppressive treatment resulting in death due to fulminant hepatitis B 159
Statin therapy decreases serum levels of high-sensitivity C-reactive protein and tumor necrosis factor-alpha in HIV-infected patients treated with ritonavir-boosted protease inhibitors. 157
Severe peripheral neuropathy with areflexic and flaccid quadriplegia complicating Legionnaires’ disease in an adult patient. 157
Membranoproliferative glomerulonephritis associated with human immunodeficiency virus, hepatitis B and hepatitis C virus coinfection: case report and literature review. 155
Methicillin-resistant staphylococci still susceptible to non-beta-lactam antibiotics. What clinical implications in nosocomially-acquired infections? 155
Efavirenz versus nevirapine in current clinical practice: a prospective, open-label observational study. 155
Novel pharmaceutical molecules against emerging resistant gram-positive cocci 155
Georges Canguilhem. Sulla Medicina. Scritti 1955-1989, Einaudi, 2007 155
First-line efavirenz versus lopinavir/ritonavir-based highly active antiretroviral therapy for naïve patients. 154
Aggressive, metastatic squamous cell carcinoma after a 46-year-old history of chronic osteomyelitis and local infectious complications: a case report 154
Neurosyphilis in a young adult: very early tertiary syphilis? 153
Antibodies reactive with C-terminus of the second conserved region of HIV-1 gp120 as possible prognostic marker and therapeutic agent for HIV disease 153
Loss of bone mass in chronically HIV-infected patients. Significant association with male gender and protease inhibitor administration 153
Polyunsaturated ethyl esters on n-3 fatty acids in HIV-infected patients with moderate hypertriglyceridemia: comparison with dietary and lifestyle changes, and fibrate therapy. 152
Legionnaires' disease associated with macular rash: two cases 152
An observational study of subcutaneous multiple lipomatosis in patients receiving highly active antiretroviral therapy. Possible correlations with metabolic abnormalities and pathogenetic insights 152
Efficacy and tolerability of a fosamprenavir-ritonavir-based versus a lopinavir-ritonavir-based antiretroviral treatment in 82 therapy-naïve patients with HIV-1 infection. 152
Hyperlactataemia and lactic acidosis in HIV-infected patients receiving antiretroviral therapy. 151
Primary Cytomegalovirus infection in otherwise healthy adults with Fever of Unknown Origin: a 3-year prospective survey 151
Antiretroviral therapy voluntarily taken at half-dosage, but fully effective after 6-10 years: a provocative issue for adherence requirements. Case report 151
Lopinavir/ritonavir trough concentrations with the tablet formulation in HIV-1-infected women during the third trimester of pregnancy. 150
Severe Community - Acquired Achromobacter denitrificans Cellulitis 149
Aderenza alla terapia antiretrovirale "autogestita" dai pazienti alla metà della posologia giornaliera raccomandata. Inattesa efficacia immunologica e virologica a lungo termine 148
Community-acquired pneumonia and sepsis caused by a multiresistant Staphylococcus aureus strain resulting in a severe and long-lasting multiple organ inflammatory involvement 147
A patient with a 12-year history characterized by four non-AIDS-related malignancies, occurring before and after the disclosure of HIV infection 146
Tuberculosis in a metropolitan area of northern Italy: epidemiological trends and public health concerns 145
Changing epidemiology of hepatitis A in the Bologna metropolitan area, northern Italy: importance of counselling and prophylactic measures for the male homo/bisexual population. 145
Antiretroviral treatment and gynecomastia: which correlations? 144
Diffuse cutaneous dissemination of visceral leishmaniasis during human immunodeficiency virus (HIV) infection, despite negligible immunodeficiency: repeated failure of liposomal amphotericin B administration, followed by successful long-term pentamidine and paromomycin administration 143
Epidemiological, clinical and therapeutic features of AIDS-related Mycobacterium kansasii infection during the HIV pandemic: an 11-year follow-up study. 143
Rosuvastatin and atorvastatin preserve renal function in HIV-1-infected patients with chronic kidney disease and hyperlipidaemia 143
Bladder carcinoma and HIV infection during the highly active antiretroviral therapy era: a rare, but intriguing association. Two case reports and literature review 143
Comparison between switching therapy from protease inhibitors to an NNRTI and lipid-lowering therapy with pravastatin or bezafibratef for the management of HAART-related dyslipidemia 142
Safety issues about nevirapine administration in HIV-infected pregnant women 142
Tubercular disease caused by Bacillus of Calmette-Guérin as a local adjuvant treatment of relapsing bladder carcinoma 142
A young patient with perinatal HIV infection treated for 17 consecutive years with antiretroviral therapy: extremely severe lipo-accumulation picture 142
An extremely different dysmetabolic profile between the two available nonucleoside reverse transcriptase inhibitors: efavirenz and nevirapine. 141
Coinfection with HIV and hepatitis C virus and immune restoration during HAART 141
In vitro antimicrobial sensitivity trends of Enterococci isolated at an Italian teaching hospital. A 2004-2007 prospective report including over 2,700 examined microbial strains 141
Virological failure at one year in triple-class experienced patients switching to raltegravir-based regimens is not predicted by baseline factors 141
Advanced acute myelogenous leukaemia (AML) during HAART-treated HIV disease, manifesting initially as a thyroid mass 141
Totale 17.256
Salva come PNG Salva come JPEG
Categoria #
all - tutte 150.049
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 150.049
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.402 0 0 0 0 0 0 0 0 0 422 354 1.626
2021/20226.973 780 380 439 685 645 477 116 468 216 347 1.170 1.250
2022/20235.626 735 882 352 681 343 328 191 269 937 160 580 168
2023/20241.201 100 241 101 101 87 159 82 71 43 111 51 54
2024/20257.001 155 1.576 763 521 1.444 314 394 105 79 253 96 1.301
2025/202614.929 815 1.663 2.162 1.606 1.936 1.094 1.216 537 2.737 1.163 0 0
Totale 56.572